← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Tetra Discovery Partners, Inc.
Grand Rapids, MI
$13,379,130
Total funding
7
Grants
Funding over time
peak $3M · FY2011–20$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$13,379,130 · 7
By mechanism
R44$10,119,228 · 3
U01$1,992,974 · 1
R43$1,041,929 · 2
R41$224,999 · 1
Investigators at Tetra Discovery Partners, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
BPN14770 Safety and Cognitive Effect in Young and Elderly Subjects$2,055,899
R44 · FY2016 · AG
PDE4B Inhibitors For Treating Major Depression$1,007,647
R44 · FY2013 · MH
PDE4B Inhibitors For Treating Major Depression$1,006,069
R44 · FY2015 · MH
Phosphodiesterase-4B (PDE4B) Inhibitors for Psychiatric Disease$991,394
R44 · FY2016 · MH
PDE4B Inhibitors For Treating Major Depression$989,992
R44 · FY2014 · MH
Phosphodiesterase-4B (PDE4B) Inhibitors for Psychiatric Disease$986,995
R44 · FY2017 · MH
Phosphodiesterase-4B (PDE4B) Inhibitors for Psychiatric Disease$982,403
R44 · FY2018 · MH
PDE4D PET Ligand$952,592
R44 · FY2018 · MH
BPN14770 Phase 1 Single Ascending Dose Clinical Trial in Healthy Subjects$694,703
U01 · FY2015 · NS
PDE4D PET Ligand$625,084
R44 · FY2020 · MH
Phosphodiesterase-4B (PDE4B) Inhibitors for Alzheimer's Disease$412,485
R44 · FY2018 · MH
Phosphodiesterase Type IV (PDE4) Isoform Selective Allosteric Modulators For Psyc$350,000
R43 · FY2011 · MH
PDE4D PET Ligand for Psychiatric Disease$346,237
R43 · FY2015 · MH
Phosphodiesterase 4 Subtype Selective Modulators for Psychiatric Disease$345,692
R43 · FY2012 · MH
PDE4D Allosteric Modulators for Treating Cognitive Impairment$300,834
U01 · FY2015 · NS
PDE4D Allosteric Modulators for Treating Cognitive Impairment$235,406
U01 · FY2014 · NS
PDE4D Allosteric Modulators for Treating Cognitive Impairment$235,406
U01 · FY2013 · NS
PDE4D Allosteric Modulators for Treating Cognitive Impairment$235,406
U01 · FY2012 · NS
PDE4B Inhibitors for Treating Brain Injury$224,999
R41 · FY2015 · NS
PDE4D Allosteric Modulators for Treating Cognitive Impairment$140,626
U01 · FY2013 · NS